Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies to Use GenVault's Storage Technology

NEW YORK (GenomeWeb News) – Life Technologies will use and offer GenVault's DNA storage technology platform under a non-exclusive supply and resale agreement, GenVault said today.

GenVault's GenTegra DNA technology is a scalable alternative to traditional freezer storage and transport systems for purified DNA. It is a dry-state platform used for extracting, preserving, recovering, and distributing biosamples at ambient temperature.

The Carlsbad, Calif.-based firm said it plans to develop future systems to store proteins and to store RNA, the latter of which the firm expects to move to the market in the fourth quarter of 2009.

"By adopting the GenTegra DNA technology platform, we will be able to store and transport purified DNA from several of our products as well as make this technology available for use by our customers," Nathan Wood, Life Technologies' VP of genomic technologies, said in a statement. "This technology allows us to eliminate much of the waste associated with these processes, which promotes a safer and cleaner environment."

Financial terms of the agreement were not released.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.